Company page
Arrivent Biopharma, Inc.
Arrivent Biopharma, Inc. is a public company traded under the ticker AVBP in the American market. With a market capitalization of approximately $1.48 billion, the company focuses on developing innovative biopharmaceutical solutions. Arrivent aims to address unmet medical needs through its research and development efforts.
- Ticker
- AVBP:NASDAQ
- Asset type
- Stock
- Market cap
- $1.48B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- Exchange
- NASDAQ
- Currency
- USD